Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 23Terminated 7Recruiting 5Unknown 2Withdrawn 1Suspended 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 5Triple Negative Breast Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Gallbladder Neoplasms 1Cholangiocarcinoma 1Bile Duct Neoplasms 1

Interventions

Protein Subunit Vaccines 1Photochemotherapy 1LY6K protein, human 1Gemcitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Bile Duct Neoplasms × Gemcitabine × Clear all
NCT00624182 2015-06-23

Gemcitabine With Peptide Vaccine Therapy in Treating Patients With Bile Duct Cancer

Akita University Hospital

Phase 1 Suspended
9 enrolled
Gastrointestinal

Bile Duct Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡